/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

V

Vanessa Orsini

Novartis (Switzerland)(CH)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

18

Papers

1.4K

Citations

12

h-index

12

i10-index

Vanessa Orsini is an academic researcher from Novartis (Switzerland). The author has contributed to research in topics: Liver physiology and pathology & Wnt/β-catenin signaling in development and cancer & Hippo pathway signaling and YAP/TAZ. The author has an h-index of 12, co-authored 16 publications.

Research Topics

Liver physiology and pathology Wnt/β-catenin signaling in development and cancer Hippo pathway signaling and YAP/TAZ Liver Disease Diagnosis and Treatment Pancreatic function and diabetes

Papers by this author

works

NIBR-LTSi is a selective LATS kinase inhibitor activating YAP signaling and expanding tissue stem cells in vitro and in vivo

2024 · Cell stem cell · 27 citations

https://doi.org/10.1016/j.stem.2024.03.003

Kenji Namoto Clara Baader Vanessa Orsini Alexandro Landshammer

Research topics

topics

Liver physiology and pathology

Wnt/β-catenin signaling in development and cancer

Hippo pathway signaling and YAP/TAZ

Liver Disease Diagnosis and Treatment

Pancreatic function and diabetes

Chat about Author

Papers

Chat

Click to start Chat